type 1 diabetes and glp 1 GLP-1 for Weight Loss Can Type 1 and Type

ADDITIONAL FINDINGS OF POTENTIAL MECHANISTIC INTEREST Utility of bioinformatic databases notwithstanding, there are interpretive limits to their use

We observed significant variability in the thoroughness of clinical evaluations

However, in MASH with significant fibrosis ( F2), pharmacological therapy provides measurable clinical benefits and should be considered with priority, especially if obesity or T2DM coexist (Fig

Preclinical and translational studies suggest semaglutide may reduce neuroinflammation, promote neurogenesis, and act on the same reward pathways involved in addiction and compulsive behavior

Diabetes, Obesity and Metabolism, 27(1), 4556